RLAY on XNAS, Health Care, Relay Therapeutics, Inc., job postings
Measures activity, not value. Not investment advice.
Shares up 153% in a year, but insiders sold $120.7M in 90 days while short interest reached 20%.
BadNet loss $293.6M over 12 months; cash on hand $124.2M
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Industry
Biological products, (no diagnostic substances) (Health Care)
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $81.7M.
31 Dec 2021RevenueNet incomeNet losstallest bar $98.5M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
–
-$81.7M
30 Jun 2026
$350K
-$83.7M
31 Mar 2026
$3.0M
-$73.3M
31 Dec 2025
$7.0M
-$54.9M
30 Sep 2025
$0
-$74.1M
30 Jun 2025
$677K
-$70.4M
31 Mar 2025
$7.7M
-$77.1M
31 Dec 2024
$0
-$76.0M
30 Sep 2024
$0
-$88.1M
30 Jun 2024
$0
-$92.2M
31 Mar 2024
$10.0M
-$81.4M
31 Dec 2023
–
-$83.5M
30 Sep 2023
$25.2M
-$65.7M
30 Jun 2023
$119K
-$98.5M
31 Mar 2023
$226K
-$94.2M
31 Dec 2022
$253K
-$67.5M
30 Sep 2022
$344K
-$84.2M
30 Jun 2022
$365K
-$76.8M
31 Mar 2022
$419K
-$62.0M
31 Dec 2021
–
-$67.5M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
–
$8.4M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
–
+8.2%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$293.6M
-$297.6M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$1.50
-$1.72
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
70.4%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
-98.6%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
–
–
-47.8%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-41.2%
-58.2%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$124.2M
$91.6M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$0
$0
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$124.2M (net cash)
-$91.6M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.0
0.0
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$3.71
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
21.6
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
–
8.0
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
6.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
4.3
2.0
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider buy/sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$120.7M
bought $0, sold $120.7M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+1.6%
259 13F filers vs 255
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
over 100%
231.1M shares held by 13F filers (30 Sep 2026) of 221.0M outstanding (30 Oct 2026); above 100%: the share count is probably stale
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
20%
43.6M shares sold short (30 Oct 2026) of 221.0M outstanding (30 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
20.7
43.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-0.9%
44.0M shares sold short in the report before, 43.6M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
62%
62% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%
News iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
19
19 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
19×
19 articles in the last 7 days; its usual week has 1.
Unusual now sharp changes in the last 90 days, compared with its own past
Short interest 43.6M, 1.9× a year earlier
Price $16.12 on 20 Nov 2026, +153% over 12 months (12-month range $6.38 to $20.75)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders sold a net $130.7M in the last 12 months (the 12 months before: -$6.6M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.Revenue per quarter. Revenue $350K in the latest quarter, -48% on a year earlier.Capital spending per quarter. Capital spending $0 in the latest quarter.Institutional holders (13F filers). 259 13F filers reported holding it in the latest 13F quarter, +38% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.
Quarter ended 31 Mar 2022: $419K, -56% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $365K, -57% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $344K, -48% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $253K; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $226K, -46% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $119K, -67% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $25.2M, +7226% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Mar 2024: $10.0M, +4328% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $0, -100% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2024: $0, -100% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2024: $0; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $7.7M, -23% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $677K; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $0; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $7.0M; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $3.0M, -61% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $350K, -48% on a year earlier; public on 7 Aug 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $880K, +1275% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $2.8M, +487% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $1.9M, +390% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $2.1M, +21% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $2.3M, +163% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $1.9M, -31% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $1.5M, -19% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $590K, -72% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $118K, -95% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $1.8M, -7.0% on a year earlier; public on 3 May 2024
Quarter ended 30 Sep 2024: $227K, -62% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Mar 2025: $384K, -78% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $26K; public on 8 Aug 2025
Quarter ended 30 Sep 2026: $0; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 120; public on 14 Feb 2022
31 Mar 2022 report: 134; public on 16 May 2022
30 Jun 2022 report: 142; public on 15 Aug 2022
30 Sep 2022 report: 151; public on 14 Nov 2022
31 Dec 2022 report: 156; public on 14 Feb 2023
31 Mar 2023 report: 150; public on 15 May 2023
30 Jun 2023 report: 153; public on 14 Aug 2023
30 Sep 2023 report: 161; public on 14 Nov 2023
31 Dec 2023 report: 167; public on 14 Feb 2024
31 Mar 2024 report: 181; public on 15 May 2024
30 Jun 2024 report: 168; public on 14 Aug 2024
30 Sep 2024 report: 189; public on 14 Nov 2024
31 Dec 2024 report: 198; public on 14 Feb 2025
31 Mar 2025 report: 202; public on 15 May 2025
30 Jun 2025 report: 199; public on 14 Aug 2025
30 Sep 2025 report: 188; public on 14 Nov 2025
31 Dec 2025 report: 217; public on 17 Feb 2026
31 Mar 2026 report: 235; public on 15 May 2026
30 Jun 2026 report: 255; public on 14 Aug 2026
30 Sep 2026 report: 259; public on 16 Nov 2026
What is unusual now
Made public in the last 90 days: it had 43.6M shares sold short in the 31 Aug 2026 report, 1.9× the same report last year; it also had 41.4M shares sold short in the 14 Aug 2026 report, 1.8× the same report last year. 4 sharp changes in all.
Short interest spike: had 40.3M shares sold short in the 31 Jul 2026 report, 1.8× the same report last year Public on 12 Aug 2026.
Changes and notable records, by the date each became public
10 Oct 2026Short interest and volume change
had 46.7M shares sold short in the 30 Sep 2026 report, 2.1× the same report last year.
Same report last year: 22.6M; its normal report is 23.6M.
See the evidence
This period
46.7M (the 30 Sep 2026 report)
Normal report (median of 24 earlier)
23.6M
Typical spread (median absolute deviation)
3.8M
How far from its usual level
+4.1
Same report last year
22.6M
History used
2,252 days
the 30 Sep 2026 report24 earlier reportsnormal: 23.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 44.5M shares sold short in the 15 Sep 2026 report, 2.0× the same report last year.
Same report last year: 22.5M; its normal report is 22.9M.
See the evidence
This period
44.5M (the 15 Sep 2026 report)
Normal report (median of 24 earlier)
22.9M
Typical spread (median absolute deviation)
3.3M
How far from its usual level
+4.5
Same report last year
22.5M
History used
2,237 days
the 15 Sep 2026 report24 earlier reportsnormal: 22.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 43.6M shares sold short in the 31 Aug 2026 report, 1.9× the same report last year.
Same report last year: 22.7M; its normal report is 22.7M.
See the evidence
This period
43.6M (the 31 Aug 2026 report)
Normal report (median of 24 earlier)
22.7M
Typical spread (median absolute deviation)
2.8M
How far from its usual level
+5.0
Same report last year
22.7M
History used
2,222 days
the 31 Aug 2026 report24 earlier reportsnormal: 22.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 41.4M shares sold short in the 14 Aug 2026 report, 1.8× the same report last year.
Same report last year: 22.7M; its normal report is 22.7M.
See the evidence
This period
41.4M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
22.7M
Typical spread (median absolute deviation)
2.6M
How far from its usual level
+4.9
Same report last year
22.7M
History used
2,205 days
the 14 Aug 2026 report24 earlier reportsnormal: 22.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 40.3M shares sold short in the 31 Jul 2026 report, 1.8× the same report last year.
Same report last year: 22.4M; its normal report is 22.6M.
See the evidence
This period
40.3M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
22.6M
Typical spread (median absolute deviation)
1.9M
How far from its usual level
+6.4
Same report last year
22.4M
History used
2,191 days
the 31 Jul 2026 report24 earlier reportsnormal: 22.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 34.4M shares sold short in the 29 May 2026 report, 1.5× the same report last year.
Same report last year: 22.6M; its normal report is 22.4M.
See the evidence
This period
34.4M (the 29 May 2026 report)
Normal report (median of 24 earlier)
22.4M
Typical spread (median absolute deviation)
820K
How far from its usual level
+5.4
Same report last year
22.6M
History used
2,128 days
the 29 May 2026 report24 earlier reportsnormal: 22.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 41 13F filers open a new position in the quarter ended 30 Sep 2024, 2.2× the same quarter last year.
Same quarter last year: 19; its normal quarter is 24.5.
See the evidence
This period
41 (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
24.5
Typical spread (median absolute deviation)
2
How far from its usual level
+5.5
Same quarter last year
19
History used
1,461 days
the quarter ended 30 Sep 20248 earlier quartersnormal: 24.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
reported revenue of $10.0M for the quarter ended 31 Mar 2024, 44× the same quarter last year.
Same quarter last year: $226K; its normal quarter is $354K.
See the evidence
This period
$10.0M (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
$354K
Typical spread (median absolute deviation)
$115K
How far from its usual level
+9.7
Same quarter last year
$226K
History used
1,096 days
the quarter ended 31 Mar 20248 earlier quartersnormal: $354K
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $25.2M for the quarter ended 30 Sep 2023, 73× the same quarter last year.
Same quarter last year: $344K; its normal quarter is $354K.
See the evidence
This period
$25.2M (the quarter ended 30 Sep 2023)
Normal quarter (median of 8 earlier)
$354K
Typical spread (median absolute deviation)
$115K
How far from its usual level
+24.8
Same quarter last year
$344K
History used
913 days
the quarter ended 30 Sep 20238 earlier quartersnormal: $354K
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Not listed: 283 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it